TRC-00496 | Ipilimumab (Human) ELISA Kit | 96 Well
Product Overview
A Sandwich ELISA kit for the quantitative measurement of Ipilimumab in human serum or plasma.
Ipilimumab is a fully human IgG1κ antibody that binds to CTLA-4 (cytotoxic T lymphocyte-associated antigen 4), a molecule on T-cells that is indicated for unresectable or metastatic melanoma. The absence or presence of CTLA-4 can augment or suppress the immune system's T-cell response in fighting disease. Ipilimumab is designed to block the activity of CTLA-4, thereby sustaining an active immune response in its attack on cancer cells. The proposed mechanism of action is indirect and maybe through T-cell - mediated anti-tumor immune responses. Ipilimumab ELISA kit has been developed for specific quantification of Ipilimumab concentration in human serum or plasma with high sensitivity and reproducibility.
Assay Information
| Assay Format | Sandwich ELISA |
| Species Reactivity | Human |
| Sample Type | Human serum and plasma |
| Detection Method | Absorbance (450 nm) |
| Detection Wavelength | 450 nm |
| Kit Size | 96 Well |
Performance Data
| Detection Range | 30 - 1000 ng/ml |
| Sensitivity | 30 ng/ml |
Applications
This ELISA kit is used for quantitative measurement of Ipilimumab in human serum and plasma
Features & Benefits
- Designed for quantitative measurement of Ipilimumab.
- Assay format: Sandwich ELISA.
- Sample type: Human serum and plasma.
- Detection method: Absorbance (450 nm).
- Detection Range: 30 - 1000 ng/ml
- Sensitivity: 30 ng/ml
- Kit size: 96 Well.
Storage & Shipping
| Storage | +4°C |
| Shipping | Gel Pack |
| Shelf Life | 12 Months |
Product Details
| Catalog Number | TRC-00496 |
| Analyte / Target | Ipilimumab |
| Alternate Name | CD, GSE, GRD4, ALPS5, CD152, CTLA-4, IDDM12, CELIAC3, CTLA4 |